Toward a More Proactive Health Care System
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
Our Latest Thinking on the Health Care Industry
Explore BCG’s latest thought leadership on health care to plan your company’s next move.
Featured Insights
Big Changes Are Coming to Pharma Contract Research Organizations
Even in a strong market, CROs are facing some longer-term challenges that could reshape the industry in the next five to ten years.
The Cash Generics Opportunity in Health Care
The cash generics market has the potential to become a $15 billion market by 2030. Here’s how incumbents and new entrants should prepare.
For Pharmaceutical Companies, Three Steps to Value with Generative AI
New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.
A Strategic Approach to Cost in Biopharma
Manufacturing costs are rising rapidly, with no end in sight. Leaders that balance the various tradeoffs can remain competitive over the long run.
The Second Opinion That Unlocks Best-in-Class Pharma Launches
The Team B approach involves assembling an independent cross-functional team to conduct rapid reviews of launch plans and market conditions for new pharmaceutical products.
Delivering Customer-Centric Patient Experiences in Biopharma
Biopharma companies can leverage new sources of patient data and technology to create more personalized patient experiences that have the potential to deliver better health outcomes.
Gabriele Ricci on Leading Takeda’s Digital Transformation
The global biopharma company’s chief data and technology officer discusses its initiative to inject digital capabilities across the value chain and the importance of prioritizing patient outcomes.
Biogen’s CFO on Leading a People-First Transformation
Mike McDonnell explains how the global biotech is charting new paths to patients via Fit for Growth, its corporate transformation initiative.
Pfizer’s Digital Transformation
Chief Digital and Technology Officer Lidia Fonseca explains how Pfizer is leveraging digital and data across the value chain and the biggest wins so far.
CEO Paul Hudson on Sanofi’s Climate Ambition
Hudson discusses the company’s commitment to reaching net zero emissions by 2045.
Personalized: Customer Strategy in the Age of AI
Personalization is a $2 trillion opportunity. BCG's new book offers a playbook for capturing your share of this personalization prize in the health care industry.
Learn More About Personalized
Benchmark Your Personalization Readiness Now
In Health Care, Maximizing AI Is About Managing Change
Health care companies can unlock AI's potential and drive sales growth by prioritizing change management—not just technology—says BCG’s Basir Mustaghni.
Facing Headwinds, Health Systems Can Learn from Airlines
To thrive during turbulent economic times, health systems can learn from the aviation industry, which embraced novel diversification approaches to maintain revenue stability and improve profitability.
BCG-WEF Project: Digital Health Care Transformation
While digital, data, and AI have extraordinary potential to revolutionize our global health care systems, they have yet to deliver a transformative impact. How can the public and private sectors accelerate progress?
Are Payers and Providers Ready for Digital Change in Health Care?
The latest technologies hold tremendous promise for health care, but they also pose significant challenges. Not all organizations are prepared to take advantage of the tech trends.
Making Medtech More Equitable
By developing products for a broader base of patients and markets, medtech companies can improve health outcomes, generate business advantages, and contribute to healthier societies overall.
Medtech’s Path to a Circular Future
Most environmental waste generated by the health care sector comes from medtech products. For a sector focused on improving quality of life, reducing waste and greenhouse gases is imperative.
Medtech Companies Must Move Faster on Generative AI
To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.
Medtech’s New Era of Collaboration and Innovation
Medtech management teams face an unfamiliar list of questions. The players that can successfully navigate the challenging terrain will be the winners of the 2020s.
Predicting the Impact of Climate Change on Malaria
Extreme weather events such as cyclones and floods will drive increases in the incidence of sickness and death from malaria in Africa, according to a new study.
Addressing Challenges at the Intersection of Climate and Health
BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.
Human Health Depends on Planetary Health
Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.
Embedding Health Equity into the Heart of Biopharma
The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.